The Brain Dynamics Center, University of Sydney Medical School and Westmead Millennium Institute, Sydney, NSW, Australia.
Neuropsychopharmacology. 2013 Apr;38(5):863-71. doi: 10.1038/npp.2012.252. Epub 2012 Dec 5.
Functional neuroimaging studies have implicated dysregulation of prefrontal circuits in major depressive disorder (MDD), and these circuits are a viable target for predicting treatment outcomes. However, because of the heterogeneity of tasks and samples used in studies to date, it is unclear whether the central dysfunction is one of prefrontal hyperreactivity or hyporeactivity. We used a standardized battery of tasks and protocols for functional magnetic resonance imaging, to identify the common vs the specific prefrontal circuits engaged by these tasks in the same 30 outpatients with MDD compared with 30 matched, healthy control participants, recruited as part of the International Study to Predict Optimized Treatment in Depression (iSPOT-D). Reflecting cognitive neuroscience theory and established evidence, the battery included cognitive tasks designed to assess functions of selective attention, sustained attention-working memory and response inhibition, and emotion tasks to assess explicit conscious and implicit nonconscious viewing of facial emotion. MDD participants were distinguished by a distinctive biosignature of: hypoactivation of the dorsolateral prefrontal cortex during working memory updating and during conscious negative emotion processing; hyperactivation of the dorsomedial prefrontal cortex during working memory and response inhibition cognitive tasks and hypoactivation of the dorsomedial prefrontal during conscious processing of positive emotion. These results show that the use of standardized tasks in the same participants provides a way to tease out prefrontal circuitry dysfunction related to cognitive and emotional functions, and not to methodological or sample variations. These findings provide the frame of reference for identifying prefrontal biomarker predictors of treatment outcomes in MDD.
功能神经影像学研究表明,前额叶回路的失调与重度抑郁症(MDD)有关,这些回路是预测治疗效果的一个可行靶点。然而,由于迄今为止用于研究的任务和样本的异质性,尚不清楚中心功能障碍是前额叶过度反应还是低反应。我们使用了一套标准化的功能磁共振成像任务和方案,在 30 名 MDD 门诊患者和 30 名匹配的健康对照参与者中,识别出这些任务共同和特定的前额叶回路,这些参与者是抑郁症优化治疗预测国际研究(iSPOT-D)的一部分。该方案反映了认知神经科学理论和已建立的证据,包括旨在评估选择性注意、持续注意力-工作记忆和反应抑制功能的认知任务,以及评估面部情绪的显性意识和隐性非意识观看的情绪任务。MDD 参与者的特征是:在工作记忆更新和意识负面情绪处理过程中,背外侧前额叶皮层的活动减少;在工作记忆和反应抑制认知任务中,背内侧前额叶皮层的活动增加,在意识处理正性情绪时,背内侧前额叶皮层的活动减少。这些结果表明,在相同的参与者中使用标准化任务可以梳理出与认知和情绪功能相关的前额叶回路功能障碍,而不是与方法学或样本变化相关的障碍。这些发现为识别 MDD 治疗效果的前额叶生物标志物预测提供了参考框架。